Evita Life Science is focused on the development and commercialisation of formulations and compounds for infectious disease, cancer, inflammatory disease, metabolic disease and neurodegenerative disease.
Our product pipeline encompasses hand and surface disinfectant and sanitiser products and formulations, to address the urgent needs in the fight of disease causing bacteria and viruses.
On the active ingredients side, natural products continue to play a highly significant role in the drug discovery and development process. Evita Life Science isolates and purifies naturally derived product candidates with novel mechanisms of action striking at the biological complexities of disease. The product portfolio is internally generated from Evita’s proprietary drug discovery technology.
Evita’s innovative medicinal chemistry platform explores Structure-Activity Relationship (SAR) and delivers untapped sources of novel drug candidates.